\-\ Texto\\:\\ \ \(0\)\
\-\ examination\\:\\ erythematous\\,\\ indurated\\,\\ waxy\\ confluent\\ plaques\\ over\\ bilateral\\ lower\\ extremities\\ with\\ hypererythematous\\ borders\\.\\ bullae\\ were\\ present\\ overlying\\ these\\ waxy\\ plaques\\ on\\ the\\ lateral\\ aspect\\ of\\ the\\ feet\\.\\ scattered\\,\\ round\\,\\ erythematous\\ papules\\ and\\ plaques\\ over\\ the\\ trunk\\ and\\ upper\\ extremities\\.\ \(0\)\
\-\ course\\:\\ prednisone\\ therapy\\ was\\ initiated\\ at\\ 80\\ mg\\ qd\\ and\\ decreased\\ by\\ 20\\ mg\\ per\\ day\\ per\\ week\\.\\ erythema\\ and\\ induration\\ of\\ the\\ plaques\\ as\\ well\\ as\\ pruritus\\ were\\ markedly\\ decreased\\.\\ the\\ patient\\ is\\ now\\ maintained\\ on\\ potent\\ topical\\ steroids\\ qd\\.\\ internal\\ medicine\\ evaluation\\ to\\ rule\\ out\\ neoplasia\\ and\\ other\\ causes\\ of\\ a\\ hypercoagulable\\ state\\ was\\ negative\\.\ \(0\)\
\-\ laboratory\\:\\ cbc\\,\\ antithrombin\\ 3\\,\\ ua\\,\\ protein\\ c\\,\\ protein\\ s\\,\\ spep\\,\\ rpr\\,\\ anticardiolipin\\,\\ lft\\'s\\,\\ chemistries\\,\\ factor\\ v\\ leiden\\,\\ all\\ wnl\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ perivascular\\ and\\ interstitial\\ eosinophils\\ and\\ lymphocytes\\ throughout\\ the\\ papillary\\ and\\ reticular\\ dermis\\.\\ focal\\ collagen\\ bundles\\ laden\\ with\\ eosinophil\\ granules\\.\\ no\\ evidence\\ of\\ panniculitis\\,\\ vasculitis\\ or\\ interface\\ dermatitis\\.\ \(0\)\
\-\ case\\ 14\\ \\(27th\\ annual\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ 2003\\)\\ well\\'s\\ syndrome\\ \\(eosinophilic\\ cellulitis\\)\ \(0\)\
\-\ history\\:\\ 53\\ year\\-old\\ caucasian\\ male\\ fractured\\ his\\ right\\ ankle\\ one\\ month\\ later\\ developing\\ an\\ ipsilateral\\ deep\\ venous\\ thrombosis\\ and\\ pulmonary\\ embolism\\.\\ he\\ then\\ developed\\ a\\ contralateral\\ deep\\ venous\\ thrombosis\\ after\\ being\\ placed\\ on\\ coumadin\\.\\ soon\\ thereafter\\,\\ he\\ received\\ a\\ blood\\ transfusion\\ while\\ undergoing\\ an\\ angiograrn\\ and\\ developed\\ an\\ urticarial\\ transfusion\\ reaction\\ over\\ his\\ trunk\\ coincident\\ with\\ small\\,\\ indurated\\ red\\ plaques\\ on\\ the\\ lower\\ extremities\\.\\ over\\ the\\ last\\ 3\\ months\\,\\ the\\ plaques\\ have\\ spread\\ up\\ both\\ extremities\\ and\\ the\\ patient\\ has\\ developed\\ pruritic\\ erythematous\\ papules\\ over\\ his\\ abdomen\\ and\\ neck\\.\\ within\\ one\\ week\\ of\\ his\\ initial\\ presentation\\ to\\ dermatology\\,\\ he\\ developed\\ total\\ body\\ pruritus\\,\\ erythematous\\ papules\\ and\\ plaques\\ over\\ his\\ trunk\\ and\\ upper\\ extremities\\,\\ and\\ bullae\\ on\\ the\\ lateral\\ aspect\\ of\\ his\\ feet\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ plaques\\:\\ 0\\.3739516955874776\ \(0\)\
\-\ erythematous\\:\\ 0\\.21498959477042157\ \(0\)\
\-\ extremities\\:\\ 0\\.20119498470339883\ \(0\)\
\-\ his\\:\\ 0\\.19267584032137863\ \(0\)\
\-\ papules\\:\\ 0\\.18155690601751062\ \(0\)\
\-\ trunk\\:\\ 0\\.1768257483569305\ \(0\)\
\-\ over\\:\\ 0\\.17665374547535684\ \(0\)\
\-\ waxy\\:\\ 0\\.16935579119382724\ \(0\)\
\-\ and\\:\\ 0\\.16412071737161238\ \(0\)\
\-\ developed\\:\\ 0\\.15713697841654795\ \(0\)\
\-\ pruritus\\:\\ 0\\.14361981171589047\ \(0\)\
\-\ indurated\\:\\ 0\\.13460656061008497\ \(0\)\
\-\ bullae\\:\\ 0\\.13460656061008497\ \(0\)\
\-\ the\\:\\ 0\\.12678430290333223\ \(0\)\
\-\ transfusion\\:\\ 0\\.12483986062253968\ \(0\)\
\-\ qd\\:\\ 0\\.12246668713352962\ \(0\)\
\-\ dermatology\\:\\ 0\\.10361935090273668\ \(0\)\
\-\ feet\\:\\ 0\\.09953067200939479\ \(0\)\
\-\ protein\\:\\ 0\\.0982786526207294\ \(0\)\
\-\ he\\:\\ 0\\.09406439000139537\ \(0\)\
\-\ mg\\:\\ 0\\.09244021447128853\ \(0\)\
\-\ per\\:\\ 0\\.08788961776798651\ \(0\)\
\-\ thrombosis\\:\\ 0\\.08634167280284993\ \(0\)\
\-\ hypererythematous\\:\\ 0\\.08467789559691362\ \(0\)\
\-\ angiograrn\\:\\ 0\\.08467789559691362\ \(0\)\
\-\ deep\\:\\ 0\\.08243396812810187\ \(0\)\
\-\ antithrombin\\:\\ 0\\.08091424986843306\ \(0\)\
\-\ anticardiolipin\\:\\ 0\\.08091424986843306\ \(0\)\
\-\ urticarial\\:\\ 0\\.08091424986843306\ \(0\)\
\-\ on\\:\\ 0\\.07995840070094393\ \(0\)\
\-\ potent\\:\\ 0\\.07824390072742943\ \(0\)\
\-\ eosinophil\\:\\ 0\\.07824390072742943\ \(0\)\
\-\ coincident\\:\\ 0\\.07824390072742943\ \(0\)\
\-\ granules\\:\\ 0\\.07617261701658132\ \(0\)\
\-\ venous\\:\\ 0\\.07560731019725025\ \(0\)\
\-\ chemistries\\:\\ 0\\.07448025499894886\ \(0\)\
\-\ laden\\:\\ 0\\.07448025499894886\ \(0\)\
\-\ leiden\\:\\ 0\\.073049383301058\ \(0\)\
\-\ induration\\:\\ 0\\.07180990585794524\ \(0\)\
\-\ spep\\:\\ 0\\.07180990585794524\ \(0\)\
\-\ panniculitis\\:\\ 0\\.07180990585794524\ \(0\)\
\-\ week\\:\\ 0\\.07122824804891315\ \(0\)\
\-\ aspect\\:\\ 0\\.06831956509593048\ \(0\)\
\-\ hypercoagulable\\:\\ 0\\.06804626012946466\ \(0\)\
\-\ pruritic\\:\\ 0\\.06804626012946466\ \(0\)\
\-\ decreased\\:\\ 0\\.06559610602655848\ \(0\)\
\-\ rpr\\:\\ 0\\.06537591098846103\ \(0\)\
\-\ lft\\:\\ 0\\.06537591098846103\ \(0\)\
\-\ eosinophils\\:\\ 0\\.06537591098846103\ \(0\)\
\-\ thereafter\\:\\ 0\\.06481317551658584\ \(0\)\
\-\ bundles\\:\\ 0\\.0642826144009841\ \(0\)\
\-\ neoplasia\\:\\ 0\\.06378074663896102\ \(0\)\
\-\ dermatitis\\:\\ 0\\.06378074663896102\ \(0\)\
\-\ topical\\:\\ 0\\.06285174270309322\ \(0\)\
\-\ perivascular\\:\\ 0\\.06285174270309322\ \(0\)\
\-\ 27th\\:\\ 0\\.06241993031126984\ \(0\)\
\-\ of\\:\\ 0\\.062171983312382086\ \(0\)\
\-\ confluent\\:\\ 0\\.06123334356676481\ \(0\)\
\-\ an\\:\\ 0\\.06074321780399279\ \(0\)\
\-\ one\\:\\ 0\\.06063223312211741\ \(0\)\
\-\ reticular\\:\\ 0\\.06051896867250354\ \(0\)\
\-\ dermis\\:\\ 0\\.05985566566769528\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.05954098154913235\ \(0\)\
\-\ coumadin\\:\\ 0\\.05894191611897683\ \(0\)\
\-\ maintained\\:\\ 0\\.05865628458278927\ \(0\)\
\-\ soon\\:\\ 0\\.05865628458278927\ \(0\)\
\-\ initiated\\:\\ 0\\.057848619531499904\ \(0\)\
\-\ interface\\:\\ 0\\.057848619531499904\ \(0\)\
\-\ fractured\\:\\ 0\\.05759429423912397\ \(0\)\
\-\ upper\\:\\ 0\\.05659086437725858\ \(0\)\
\-\ prednisone\\:\\ 0\\.05577733582065179\ \(0\)\
\-\ cellulitis\\:\\ 0\\.0555733211798489\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.054799348697280606\ \(0\)\
\-\ were\\:\\ 0\\.05458795057331531\ \(0\)\
\-\ lower\\:\\ 0\\.054114580077958864\ \(0\)\
\-\ collagen\\:\\ 0\\.05374739869260539\ \(0\)\
\-\ state\\:\\ 0\\.053421670798211085\ \(0\)\
\-\ histopathology\\:\\ 0\\.053421670798211085\ \(0\)\
\-\ borders\\:\\ 0\\.053262995267796855\ \(0\)\
\-\ seminar\\:\\ 0\\.053262995267796855\ \(0\)\
\-\ contralateral\\:\\ 0\\.05295355686425984\ \(0\)\
\-\ uniformed\\:\\ 0\\.052802621953466924\ \(0\)\
\-\ lateral\\:\\ 0\\.05255542122846885\ \(0\)\
\-\ services\\:\\ 0\\.05194518577761744\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.05154444905087947\ \(0\)\
\-\ well\\:\\ 0\\.05127688926811475\ \(0\)\
\-\ developing\\:\\ 0\\.050671644837593524\ \(0\)\
\-\ ua\\:\\ 0\\.050553397474273086\ \(0\)\
\-\ red\\:\\ 0\\.04987390206676933\ \(0\)\
\-\ factor\\:\\ 0\\.04965802506973052\ \(0\)\
\-\ wnl\\:\\ 0\\.04965802506973052\ \(0\)\
\-\ 53\\:\\ 0\\.049551940572301445\ \(0\)\
\-\ papillary\\:\\ 0\\.049343340951167595\ \(0\)\
\-\ vasculitis\\:\\ 0\\.0491393263103647\ \(0\)\
\-\ annual\\:\\ 0\\.04893969942312558\ \(0\)\
\-\ undergoing\\:\\ 0\\.04809098037969761\ \(0\)\
\-\ interstitial\\:\\ 0\\.04800129569658988\ \(0\)\
\-\ embolism\\:\\ 0\\.04800129569658988\ \(0\)\
\-\ erythema\\:\\ 0\\.04791246925327671\ \(0\)\
\-\ 2003\\:\\ 0\\.047650978933535135\ \(0\)\
\-\ spread\\:\\ 0\\.0475654272450597\ \(0\)\
\-\ caucasian\\:\\ 0\\.047068042599516594\ \(0\)\
\-\ markedly\\:\\ 0\\.046750668351246\ \(0\)\
\-\ ankle\\:\\ 0\\.046750668351246\ \(0\)\
\-\ medicine\\:\\ 0\\.046672991810163954\ \(0\)\
\-\ steroids\\:\\ 0\\.046519561994775645\ \(0\)\
\-\ scattered\\:\\ 0\\.04607392638000844\ \(0\)\
\-\ received\\:\\ 0\\.04607392638000844\ \(0\)\
\-\ overlying\\:\\ 0\\.045110454181395275\ \(0\)\
\-\ reaction\\:\\ 0\\.04504531501939869\ \(0\)\
\-\ cbc\\:\\ 0\\.044178337993196114\ \(0\)\
\-\ round\\:\\ 0\\.0433854654430315\ \(0\)\
\-\ total\\:\\ 0\\.0433854654430315\ \(0\)\
\-\ last\\:\\ 0\\.04306535466983209\ \(0\)\
\-\ as\\:\\ 0\\.04254344595915046\ \(0\)\
\-\ rule\\:\\ 0\\.04202464911534032\ \(0\)\
\-\ 80\\:\\ 0\\.041303331593611554\ \(0\)\
\-\ placed\\:\\ 0\\.04126005742436508\ \(0\)\
\-\ causes\\:\\ 0\\.04000979288824132\ \(0\)\
\-\ 14\\:\\ 0\\.03953178707378413\ \(0\)\
\-\ course\\:\\ 0\\.039111384999920375\ \(0\)\
\-\ throughout\\:\\ 0\\.038941685712399934\ \(0\)\
\-\ laboratory\\:\\ 0\\.0384504445027582\ \(0\)\
\-\ later\\:\\ 0\\.03789333978173284\ \(0\)\
\-\ then\\:\\ 0\\.03748203168914904\ \(0\)\
\-\ biopsy\\:\\ 0\\.03711576322515643\ \(0\)\
\-\ was\\:\\ 0\\.03690690136096091\ \(0\)\
\-\ being\\:\\ 0\\.036897346265729\ \(0\)\
\-\ presentation\\:\\ 0\\.036449602811524234\ \(0\)\
\-\ now\\:\\ 0\\.03634731756173999\ \(0\)\
\-\ internal\\:\\ 0\\.035684891527265554\ \(0\)\
\-\ initial\\:\\ 0\\.03552059887565643\ \(0\)\
\-\ body\\:\\ 0\\.03484767442143393\ \(0\)\
\-\ out\\:\\ 0\\.03480450089015365\ \(0\)\
\-\ patient\\:\\ 0\\.03444367643030576\ \(0\)\
\-\ while\\:\\ 0\\.034220253722691545\ \(0\)\
\-\ 20\\:\\ 0\\.03415978254796524\ \(0\)\
\-\ examination\\:\\ 0\\.0338826786122776\ \(0\)\
\-\ day\\:\\ 0\\.03372797015614185\ \(0\)\
\-\ negative\\:\\ 0\\.032780719128706365\ \(0\)\
\-\ neck\\:\\ 0\\.032390720712826254\ \(0\)\
\-\ abdomen\\:\\ 0\\.03230806395567662\ \(0\)\
\-\ evaluation\\:\\ 0\\.032291620563437935\ \(0\)\
\-\ pulmonary\\:\\ 0\\.0322752062488311\ \(0\)\
\-\ month\\:\\ 0\\.032209837721695556\ \(0\)\
\-\ syndrome\\:\\ 0\\.03192124579878499\ \(0\)\
\-\ focal\\:\\ 0\\.031672041771361764\ \(0\)\
\-\ all\\:\\ 0\\.03151961975061005\ \(0\)\
\-\ with\\:\\ 0\\.03110456552879823\ \(0\)\
\-\ shows\\:\\ 0\\.031076819145024866\ \(0\)\
\-\ months\\:\\ 0\\.030820935767459996\ \(0\)\
\-\ blood\\:\\ 0\\.03075109125063056\ \(0\)\
\-\ therapy\\:\\ 0\\.03042296427310504\ \(0\)\
\-\ evidence\\:\\ 0\\.030054257376746298\ \(0\)\
\-\ these\\:\\ 0\\.029900615924369604\ \(0\)\
\-\ both\\:\\ 0\\.0295272830661242\ \(0\)\
\-\ bilateral\\:\\ 0\\.028457054829435804\ \(0\)\
\-\ other\\:\\ 0\\.02749756375301584\ \(0\)\
\-\ small\\:\\ 0\\.0273131734165443\ \(0\)\
\-\ present\\:\\ 0\\.02717014604913018\ \(0\)\
\-\ case\\:\\ 0\\.02660129007846261\ \(0\)\
\-\ to\\:\\ 0\\.026474578861893392\ \(0\)\
\-\ have\\:\\ 0\\.026451216460139697\ \(0\)\
\-\ up\\:\\ 0\\.026192158925758997\ \(0\)\
\-\ after\\:\\ 0\\.02568670622886804\ \(0\)\
\-\ within\\:\\ 0\\.0243869408979758\ \(0\)\
\-\ has\\:\\ 0\\.024185822472081737\ \(0\)\
\-\ male\\:\\ 0\\.02357518711695734\ \(0\)\
\-\ by\\:\\ 0\\.022485459955592958\ \(0\)\
\-\ history\\:\\ 0\\.02022980246533154\ \(0\)\
\-\ at\\:\\ 0\\.019999724332898934\ \(0\)\
\-\ or\\:\\ 0\\.0184202138705822\ \(0\)\
\-\ right\\:\\ 0\\.01755497453413664\ \(0\)\
\-\ no\\:\\ 0\\.017218598887780517\ \(0\)\
\-\ is\\:\\ 0\\.014500600513766592\ \(0\)\
